Hedgehog Inhibitors Beyond Clinical Complete Response in Basal Cell Carcinoma: Should I Stop or Should I Go?

MLA

Alfieri, Salvatore, et al. “Hedgehog Inhibitors Beyond Clinical Complete Response in Basal Cell Carcinoma: Should I Stop or Should I Go?” The Oncologist, vol. 29, no. 5, May 2024, pp. e699–707. EBSCOhost, https://doi.org/10.1093/oncolo/oyad319.

APA

Alfieri, S., Romanò, R., Marceglia, S., De Giorgi, V., Peris, K., Sollena, P., Piccerillo, A., Moro, R., Gualdi, G., Ascierto, P. A., Palla, M., Paone, M., Eibenschutz, L., Spagnolo, F., Queirolo, P., Filippini, D. M., Cavalieri, S., Resteghini, C., Bergamini, C., … Bossi, P. (2024). Hedgehog Inhibitors Beyond Clinical Complete Response in Basal Cell Carcinoma: Should I Stop or Should I Go? The Oncologist, 29(5), e699–e707. https://doi.org/10.1093/oncolo/oyad319

Chicago

Alfieri, Salvatore, Rebecca Romanò, Sara Marceglia, Vincenzo De Giorgi, Ketty Peris, Pietro Sollena, Alfredo Piccerillo, et al. 2024. “Hedgehog Inhibitors Beyond Clinical Complete Response in Basal Cell Carcinoma: Should I Stop or Should I Go?” The Oncologist 29 (5): e699–707. doi:10.1093/oncolo/oyad319.